Insider · CIK 0002131829
Thomas (TC) Chan
Files at GDRX (GoodRx Holdings, Inc.). First filing -, latest -.
In brief
Thomas (TC) Chan files SEC Form 4 as officer at GDRX (GoodRx Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas (TC) Chan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 34 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +2,101 | - | - | 15,647 | 28 d ago |
| Sep 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,069 | $3.56 | $3,806 | 14,578 | 28 d ago |
| Sep 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -2,101 | $0.00 | $0 | 12,606 | 28 d ago |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +1,252 | - | - | 9,832 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -638 | $3.73 | $2,380 | 9,194 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +1,686 | - | - | 10,880 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -858 | $3.73 | $3,200 | 10,022 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +2,636 | - | - | 12,658 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,342 | $3.73 | $5,006 | 11,316 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +4,541 | - | - | 15,857 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -2,311 | $3.73 | $8,620 | 13,546 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -1,252 | $0.00 | $0 | 0 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -1,686 | $0.00 | $0 | 5,059 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -2,636 | $0.00 | $0 | 26,367 | Aug 17, 2026 |
| Aug 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -4,541 | $0.00 | $0 | 49,953 | Aug 17, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +5,792 | - | - | 11,527 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -2,947 | $3.01 | $8,870 | 8,580 | Jul 16, 2026 |
| Jul 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -5,792 | $0.00 | $0 | 57,925 | Jul 16, 2026 |
| Jun 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +1,969 | - | - | 5,706 | Jun 15, 2026 |
| Jun 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,002 | $2.65 | $2,655 | 4,704 | Jun 15, 2026 |
| Jun 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +2,100 | - | - | 6,804 | Jun 15, 2026 |
| Jun 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,069 | $2.65 | $2,833 | 5,735 | Jun 15, 2026 |
| Jun 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -1,969 | $0.00 | $0 | 0 | Jun 15, 2026 |
| Jun 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -2,100 | $0.00 | $0 | 14,707 | Jun 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +1,252 | - | - | 2,252 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -638 | $2.49 | $1,589 | 1,614 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +2,637 | - | - | 4,251 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -1,342 | $2.49 | $3,342 | 2,909 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +1,686 | - | - | 4,595 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | FTax withholding Class A Common Stock | -858 | $2.49 | $2,136 | 3,737 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -1,252 | $0.00 | $0 | 1,252 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -2,637 | $0.00 | $0 | 29,003 | May 15, 2026 |
| May 15, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Restricted Stock Unitderivative | -1,686 | $0.00 | $0 | 6,745 | May 15, 2026 |
| May 11, 2026 | GDRX GoodRx Holdings, Inc. | AGrant or award Restricted Stock Unitderivative | +54,494 | $0.00 | $0 | 54,494 | May 12, 2026 |
Questions about Thomas (TC) Chan
Answered from the filings on this page, as of the latest one.
Is Thomas (TC) Chan buying or selling?
Thomas (TC) Chan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas (TC) Chan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas (TC) Chan has 0.
Where does Thomas (TC) Chan file Form 4?
Thomas (TC) Chan has filed Form 4 at GDRX (GoodRx Holdings, Inc.) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.